Market Closed -
Nasdaq
04:00:00 2024-04-26 pm EDT
|
5-day change
|
1st Jan Change
|
12.65
USD
|
-5.31%
|
|
-5.67%
|
+28.54%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
661.6
|
199.8
|
111.5
|
63.41
|
53.96
|
69.36
|
-
|
-
|
Enterprise Value (EV)
1 |
661.6
|
199.8
|
111.5
|
63.41
|
53.96
|
69.36
|
69.36
|
69.36
|
P/E ratio
|
-5.5
x
|
-3.46
x
|
-0.78
x
|
-0.68
x
|
-0.74
x
|
-0.85
x
|
-0.8
x
|
-0.76
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
41.4
x
|
2.53
x
|
17.8
x
|
-
|
7.53
x
|
-
|
-
|
1.32
x
|
EV / Revenue
|
41.4
x
|
2.53
x
|
17.8
x
|
-
|
7.53
x
|
-
|
-
|
1.32
x
|
EV / EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EV / FCF
|
-8,132,216
x
|
-3,149,843
x
|
-
|
-749,884
x
|
-
|
-
|
-
|
-
|
FCF Yield
|
-0%
|
-0%
|
-
|
-0%
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
2,695
|
2,752
|
3,988
|
4,065
|
5,483
|
5,483
|
-
|
-
|
Reference price
2 |
245.5
|
72.60
|
27.96
|
15.60
|
9.841
|
12.65
|
12.65
|
12.65
|
Announcement Date
|
3/4/20
|
2/25/21
|
3/11/22
|
3/22/23
|
3/28/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
15.96
|
79.1
|
6.254
|
-
|
7.163
|
-
|
-
|
52.5
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-102.7
|
-64.78
|
-91.05
|
-94.11
|
-64.65
|
-84.6
|
-92.08
|
-100.3
|
Operating Margin
|
-643.44%
|
-81.89%
|
-1,455.87%
|
-
|
-902.5%
|
-
|
-
|
-190.97%
|
Earnings before Tax (EBT)
1 |
-98.41
|
-62.15
|
-132.4
|
-93.09
|
-61.2
|
-81.8
|
-89.22
|
-97.35
|
Net income
1 |
-97.63
|
-62.15
|
-129.9
|
-93.09
|
-61.23
|
-81.8
|
-89.22
|
-97.35
|
Net margin
|
-611.63%
|
-78.57%
|
-2,076.35%
|
-
|
-854.78%
|
-
|
-
|
-185.42%
|
EPS
2 |
-44.64
|
-21.00
|
-36.00
|
-23.04
|
-13.38
|
-14.88
|
-15.76
|
-16.69
|
Free Cash Flow
|
-81.35
|
-63.43
|
-
|
-84.56
|
-
|
-
|
-
|
-
|
FCF margin
|
-509.63%
|
-80.18%
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/4/20
|
2/25/21
|
3/11/22
|
3/22/23
|
3/28/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
6.254
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
7.163
|
-
|
-
|
-
|
-
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-18.88
|
-21.25
|
-23.16
|
-24.57
|
-23.4
|
-22.98
|
-19.56
|
-17.49
|
-15.05
|
-12.55
|
-18.3
|
-19.8
|
-22
|
-24.5
|
Operating Margin
|
-301.81%
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-175.22%
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-18.8
|
-62.79
|
-23.09
|
-24.46
|
-23.14
|
-22.4
|
-18.95
|
-16.9
|
-14.42
|
-10.93
|
-17.6
|
-19.1
|
-21.3
|
-23.8
|
Net income
1 |
-18.8
|
-60.26
|
-23.09
|
-24.46
|
-23.14
|
-22.4
|
-18.95
|
-16.9
|
-14.42
|
-10.96
|
-17.6
|
-19.1
|
-21.3
|
-23.8
|
Net margin
|
-300.66%
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-153.04%
|
-
|
-
|
-
|
-
|
EPS
2 |
-4.920
|
-16.44
|
-5.760
|
-6.120
|
-5.760
|
-5.520
|
-4.440
|
-3.840
|
-3.240
|
-1.740
|
-3.230
|
-3.480
|
-3.870
|
-4.300
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
11/4/21
|
3/11/22
|
5/12/22
|
8/9/22
|
11/8/22
|
3/22/23
|
5/4/23
|
8/9/23
|
11/8/23
|
3/28/24
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-81.4
|
-63.4
|
-
|
-84.6
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
|
-
|
0.47
|
2.24
|
0.1
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
0.59%
|
35.8%
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/4/20
|
2/25/21
|
3/11/22
|
3/22/23
|
3/28/24
|
-
|
-
|
-
|
Last Close Price
12.65
USD Average target price
36
USD Spread / Average Target +184.58% Consensus |
1st Jan change
|
Capi.
|
---|
| +28.54% | 69.36M | | +5.31% | 70.44B | | +10.97% | 8.94B | | -16.83% | 4.75B | | +43.48% | 4.5B | | +3.20% | 3.85B | | +18.82% | 2.38B | | -21.36% | 2.34B | | -29.67% | 2.2B | | +8.38% | 1.96B |
Specialty & Advanced Pharmaceuticals
|